Hong Kong Leisure Stock News

Why Akeso is on investors’ radars today Akeso (SEHK:9926) has attracted fresh attention after recent share price moves, with the stock showing a 1 day return of 3.1% decline and a 7 day return of 7.6% decline from its last close of HK$114. Investors are weighing these short term moves against its longer term record and the company’s current fundamentals. See our latest analysis for Akeso. While the recent 1 day and 7 day share price returns are both in decline, Akeso’s 1 year total...

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...

Abbisko Cayman (SEHK:2256) is back in focus after the U.S. FDA formally accepted the New Drug Application for pimicotinib, its oral CSF-1R inhibitor for tenosynovial giant cell tumor, following positive Phase III MANEUVER trial results. See our latest analysis for Abbisko Cayman. Investors appear to be weighing the FDA’s NDA acceptance against earlier gains, with a 1-month share price return of 7.85% and year to date share price return of 9.68%, while the 1-year total shareholder return is...

Xiaomi recently introduced a 7-year low-interest financing plan for its electric vehicles to lower monthly payments and improve affordability for first-time buyers, while CEO Lei Jun highlighted the importance of transparent marketing to build consumer trust. This move not only broadens access to Xiaomi’s EVs but also puts the spotlight on how financing design and credit risk management could influence the profitability of its auto ambitions. We will now examine how Xiaomi’s push into...

Ubtech Robotics (SEHK:9880) is back in focus after securing an Airbus order for its Walker S2 humanoid robots, following last year’s Texas Instruments deal and reporting over CN¥1.4b in humanoid robot orders for 2025. See our latest analysis for Ubtech Robotics. The Airbus order and pending acquisition circular come after a strong run in the stock, with a 30 day share price return of 27.19% and a 1 year total shareholder return of about 2.4x. This suggests momentum has picked up recently...

As global markets navigate a mixed landscape, with small-cap and value stocks gaining traction, investors are increasingly looking toward under-the-radar opportunities in Asia. Penny stocks, though often considered a relic of past trading days, still hold potential for significant growth when backed by strong financials. In this article, we explore three Asian penny stocks that stand out for their balance sheet strength and potential to uncover hidden value in today's market.

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

Sunny Optical Technology (Group) (SEHK:2382) has launched a share repurchase program authorized to buy back up to 10% of its issued share capital, with the stated objective of supporting net asset value and earnings per share. See our latest analysis for Sunny Optical Technology (Group). The buyback announcement comes after a mixed stretch for investors, with the share price at HK$63.95 following a 2.16% 1 day share price return but a 18.59% 90 day share price decline and a 69.25% 5 year...

Earlier this month, Hansoh Pharmaceutical Group announced that China’s National Medical Products Administration approved an additional indication for its innovative lung cancer drug Ameile, allowing its use with pemetrexed and platinum-based chemotherapy as a first-line treatment for certain adult EGFR-mutated NSCLC patients, marking the drug’s fifth approved indication. This latest approval meaningfully broadens Ameile’s clinical footprint in lung cancer, underscoring Hansoh’s focus on...

ZhongAn Online P & C Insurance Co., Ltd. reported that its unaudited gross written premiums for the full year 2025 were approximately RMB 35.64 billion. This full-year premium disclosure offers investors a clearer view of ZhongAn’s insurance activity scale across its various business lines. We will now consider how ZhongAn’s RMB 35.64 billion in gross written premiums shapes the company’s broader investment narrative. The best AI stocks today may lie beyond giants like Nvidia and Microsoft...

Xinyi Glass Holdings Limited's ( HKG:868 ) price-to-earnings (or "P/E") ratio of 18.1x might make it look like a sell...

Poly Property Group Co., Limited reported that its wholly-owned subsidiary Shanghai Poly Property successfully issued the first tranche of 2026 medium-term notes in January 2026, raising RMB 1,000,000,000 with a three-year term and a 2.69% annual coupon. The decision to use the proceeds to replenish internal funds previously applied to repay debt highlights a focus on maintaining liquidity and recycling capital within the group. We will now examine how this RMB 1,000,000,000 medium-term note...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

With a median price-to-sales (or "P/S") ratio of close to 7.7x in the Healthcare Services industry in Hong Kong, you...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

Key Insights JBB Builders International's significant insider ownership suggests inherent interests in company's...

You may think that with a price-to-sales (or "P/S") ratio of 0.1x Kaisa Prosperity Holdings Limited ( HKG:2168 ) is a...

When you see that almost half of the companies in the Machinery industry in Hong Kong have price-to-sales ratios (or...

With a median price-to-sales (or "P/S") ratio of close to 1.2x in the Media industry in Hong Kong, you could be...

If you are wondering whether Wynn Macau's current share price reflects its underlying value, you are not alone, and this article will walk you through what the numbers are saying. The stock recently closed at HK$5.78, with returns of a 2.0% decline over 7 days, a 6.9% decline over 30 days, a 3.7% decline year to date, but a 12.9% gain over 1 year, while the 3 year and 5 year returns stand at a 36.4% decline and a 48.9% decline respectively. Recent news flow around Wynn Macau has focused on...

There wouldn't be many who think Everest Medicines Limited's ( HKG:1952 ) price-to-sales (or "P/S") ratio of 14x is...

What financial metrics can indicate to us that a company is maturing or even in decline? Typically, we'll see the trend...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

We feel now is a pretty good time to analyse Zhejiang Leapmotor Technology Co., Ltd.'s ( HKG:9863 ) business as it...